Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Carnahan

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Molecular Therapy. Methods & Clinical Development|July 23, 2020
Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus InfectionJesse H Erasmus, Jacob Archer, Jasmine Fuerte-Stone, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2022
De novo sequencing and construction of a unique antibody for the recognition of alternative conformations of cytochrome <i>c</i> in cellsFlorencia Tomasina, Jennyfer Martínez, Ari Zeida, et al.
Frontiers in Cell and Developmental Biology|June 9, 2025
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitorsCarly R Cabel, Briana A Guzman, Elaheh Alizadeh, et al.
Nature Biotechnology|March 4, 2022
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blockingAndrea R Shiakolas, Kevin J Kramer, Nicole V Johnson, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike proteinNaveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitorsCarly R Cabel, Briana A Guzman, Elaheh Alizadeh, et al.
Plos One|December 20, 2012
Kaiso directs the transcriptional corepressor MTG16 to the Kaiso binding site in target promotersCaitlyn W Barrett, J Joshua Smith, Lauren C Lu, et al.
Cell|December 10, 2020
Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus InfectionLauren E Williamson, Theron Gilliland, Pramod K Yadav, et al.
Cell Reports. Medicine|November 7, 2023
SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypesSteven C Wall, Naveenchandra Suryadevara, Changil Kim, et al.
Cell|October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodiesPavlo Gilchuk, Charles D Murin, Robert W Cross, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Molecular Therapy. Methods & Clinical Development|July 23, 2020
Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus InfectionJesse H Erasmus, Jacob Archer, Jasmine Fuerte-Stone, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2022
De novo sequencing and construction of a unique antibody for the recognition of alternative conformations of cytochrome <i>c</i> in cellsFlorencia Tomasina, Jennyfer Martínez, Ari Zeida, et al.
Frontiers in Cell and Developmental Biology|June 9, 2025
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitorsCarly R Cabel, Briana A Guzman, Elaheh Alizadeh, et al.
Nature Biotechnology|March 4, 2022
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blockingAndrea R Shiakolas, Kevin J Kramer, Nicole V Johnson, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike proteinNaveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitorsCarly R Cabel, Briana A Guzman, Elaheh Alizadeh, et al.
Plos One|December 20, 2012
Kaiso directs the transcriptional corepressor MTG16 to the Kaiso binding site in target promotersCaitlyn W Barrett, J Joshua Smith, Lauren C Lu, et al.
Cell|December 10, 2020
Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus InfectionLauren E Williamson, Theron Gilliland, Pramod K Yadav, et al.
Cell Reports. Medicine|November 7, 2023
SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypesSteven C Wall, Naveenchandra Suryadevara, Changil Kim, et al.
Cell|October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodiesPavlo Gilchuk, Charles D Murin, Robert W Cross, et al.
Pageof 15